A BUDGET IMPACT ANALYSIS OF FIDAXOMICIN VERSUS VANCOMYCIN AND METRONIDAZOLE FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE

被引：0
|
作者：
Leinwand, B. [1 ]
机构：
[1] Avalere Hlth LLC, Washington, DC USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.1426
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PGI7
引用
收藏
页码：A632 / A633
页数：2
相关论文
共 50 条
  • [1] Budget Impact Analysis of Fidaxomicin Versus Vancomycin for the Treatment of Clostridioides difficile Infection in the United States
    Yiling Jiang
    Eric M. Sarpong
    Pamela Sears
    Engels N. Obi
    Infectious Diseases and Therapy, 2022, 11 : 111 - 126
  • [2] Real-World Budget Impact of Fidaxomicin versus Vancomycin or Metronidazole for In-Hospital Treatment of Clostridioides difficile Infection
    Whitney, Laura
    Nesnas, John
    Planche, Timothy
    ANTIBIOTICS-BASEL, 2023, 12 (01):
  • [3] Fidaxomicin versus Vancomycin for Clostridium difficile Infection
    Louie, Thomas J.
    Miller, Mark A.
    Mullane, Kathleen M.
    Weiss, Karl
    Lentnek, Arnold
    Golan, Yoav
    Gorbach, Sherwood
    Sears, Pamela
    Shue, Youe-Kong
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (05): : 422 - 431
  • [4] Proteomic Signatures of Clostridium difficile Stressed with Metronidazole, Vancomycin, or Fidaxomicin
    Maass, Sandra
    Otto, Andreas
    Albrecht, Dirk
    Riedel, Katharina
    Trautwein-Schult, Anke
    Becher, Doerte
    CELLS, 2018, 7 (11)
  • [5] Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin
    Comely, Oliver A.
    Miller, Mark A.
    Louie, Thomas J.
    Crook, Derrick W.
    Gorbach, Sherwood L.
    CLINICAL INFECTIOUS DISEASES, 2012, 55 : S154 - S161
  • [6] Fidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian Outcomes
    Lee, Christine
    Louie, Thomas J.
    Weiss, Karl
    Valiquette, Louis
    Gerson, Marvin
    Arnott, Wendy
    Gorbach, Sherwood L.
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2016, 2016 : 1 - 8
  • [7] COMPARATIVE EFFICACY OF FIDAXOMICIN, VANCOMYCIN AND METRONIDAZOLE FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION: A NETWORK META-ANALYSIS
    Okumura, H.
    Fukushima, A.
    Taieb, V
    Shoji, S.
    English, M.
    VALUE IN HEALTH, 2018, 21 : S222 - S222
  • [8] Fidaxomicin compared with vancomycin and metronidazole for the treatment of Clostridioides (Clostridium) difficile infection: A network meta-analysis
    Okumura, Hiroyuki
    Fukushima, Ayako
    Taieb, Vanessa
    Shoji, Shingo
    English, Marci
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2020, 26 (01) : 43 - 50
  • [9] COST-EFFECTIVENESS OF FIDAXOMICIN VERSUS VANCOMYCIN AND METRONIDAZOLE IN PATIENTS WITH CLOSTRIDIUM DIFFICILE INFECTION IN SPAIN
    Watt, M.
    de Nigris, E.
    McCrea, C.
    VALUE IN HEALTH, 2017, 20 (09) : A784 - A784
  • [10] Real-world comparison of fidaxomicin versus vancomycin or metronidazole in the treatment of Clostridium difficile infection: a systematic review and meta-analysis
    Dai, Jianfeng
    Gong, Jing
    Guo, Rui
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (11) : 1727 - 1737
12345